Keywords: astrazeneca, highlights, international, development, key, sustained, success

AstraZeneca highlights international development as key to sustained success

Article | 17 December 2007

David Brennan, Anglo-Swedish drug major AstraZeneca's chief executive, says that building a major international presence in research, development and commercialization ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Astra Zeneca

AstraZeneca

Go to company listing

Related Drugs

Palivizumab

Synagis

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing